CVS accused of overbilling feds $600M in scheme similar to one in Ohio

The federal government on Friday accused a drug middleman owned by CVS Health of overbilling a program that covers 9 million federal employees by $615 million over a four-year period. The audit’s findings were similar to those found by one commissioned by the Ohio Department of Medicaid in 2018. It found that pharmacy middlemen owned by CVS and UnitedHealth billed the state $224 million more for drugs that it paid pharmacists in 2017.